5 Pharma Trends for 2023: Challenges and opportunities in the post-COVID landscape
Pharma is facing a new set of launch, market access and strategic challenges as the pandemic has changed some market characteristics for good.
Our products
Pharma is facing a new set of launch, market access and strategic challenges as the pandemic has changed some market characteristics for good.
Pharmaceutical companies must ensure that each component of their product launch plan makes a meaningful contribution to return on investment (ROI).
By optimising the efficiency and impact of a launch programme, you can maintain ROI from new products at realistic levels that will keep R&D ticking over and continue providing incentives for pharma companies and their investors to pursue better health outcomes.
Medicines need to make a profit. Making launches count: pharma and biotech ROI under strain
Collaboration is a key pillar of a successful pharma launch - watch out for these 5 signs that your launch team is not collaborating effectively.
Global value dossiers are the key to getting your products to market but when they’re done badly, they waste valuable time and resource.
Successful market access team collaboration requires the backing of the whole business - here are tips for effecitve execution.
TRiBECA Knowledge needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For more information on how to unsubscribe, our privacy practices, and how we are committed to protecting and respecting your privacy, please review our Privacy Notice.